FIELD: chemistry; medicine.
SUBSTANCE: invention relates to 4-benzoylpyridine O-R-oxime derivatives of the general formula: 
where R can be: 
and: 
where R can be: 
X: oxalic acid or other organic or mineral acids, or is absent, which exhibit anticonvulsant activity, and to methods for their preparation.
EFFECT: invention provides derivatives exhibiting anticonvulsant activity and a method of preparation.
6 cl, 12 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIBENZOFURAN OXIME DERIVANTS WITH ANTICONVULSANT AND NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2744758C2 |
| DERIVATIVES OF 4-PHENYLPYRROLIDONE WITH ANTICONVULSANT AND NOOTROPIC ACTIVITY AS MEANS OF TREATING EPILEPSY AND PAROXYSMAL CONDITIONS | 2017 |
|
RU2748419C2 |
| COUMARIN, THIOCOUMARIN AND QUINOLINONE DERIVATIVES, HAVING ANTICONVULSANT ACTIVITY | 2017 |
|
RU2720510C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PAROXYSMAL CONDITIONS | 2011 |
|
RU2469722C1 |
| AMINOALKYL DERIVATIVES OF DIBENZOFURANONE OXIME EXHIBITING ANTICONVULSANT ACTIVITY | 2020 |
|
RU2773021C2 |
| CINNAMOYL DERIVATIVES OF DIBENZOFURANONE OXIME WITH ANTICONVULSANT ACTIVITY | 2023 |
|
RU2810250C1 |
| 3-BENZYLAMINOMETHYLENEPYRROLIDINE-2,4-DIONE AND ANTICONVULSANT AGENT BASED ON SAID | 1997 |
|
RU2144918C1 |
| 4-(3,4-DIBROMOTHIOPHENE CARBONYL)-2,6,8,12-TETRAACETYL-2,4,6,8,10,12-HEXAAZATETRACYCLO[5,5,0,0,0]DODECANE USED AS AN ANTICONVULSANT | 2018 |
|
RU2684107C1 |
| NEUROTROPIC DRUG AND METHOD FOR ITS PRODUCTION | 2007 |
|
RU2359962C1 |
| DERIVATIVE PYRIDOXIN FOR TREATMENT OF EPILEPSY | 2017 |
|
RU2650523C1 |
